Most agile frameworks fail in pharma because they treat Medical, Legal, and Regulatory (MLR) review as something that happens after the work, instead of something that happens inside it. The MLR SPRINT Model™ is a named, structured operating model — not another flavor of Scrum — built from Design Thinking, Systems Thinking, and Agile, and engineered to run inside the regulatory and commercial realities of pharmaceutical marketing.
The standard agile playbook — two-week sprints, daily standups, a product backlog, a sprint review — was designed for software teams shipping code. When pharma companies try to adopt it, they run into the same wall: MLR review. Medical, legal, and regulatory review is the single biggest structural bottleneck in pharmaceutical marketing. The industry average is 8-12 weeks to approve a single promotional asset. By the time a campaign clears review, the competitive landscape has shifted, the congress is over, and the field team has moved on to the next priority.
Most consultants respond to this by telling teams to ‘iterate faster’ or ‘break work into smaller pieces.’ These are correct in principle and useless in practice, because they ignore the structural design of the review process itself. The MLR gate sits at the end of a sequential workflow. No amount of sprint planning changes the fact that a reviewer will not see the asset until it’s finished, and will not approve it until it meets a compliance standard that wasn’t part of the design brief.
The MLR SPRINT Model™ is built to solve this specific structural problem. It doesn’t replace agile — it redesigns the operating model so that agile can actually work in a regulated environment.
Before we redesign any workflow, we reframe the problem. Most organizations describe their MLR challenge as ‘reviewers are too slow.’ Design Thinking forces us to look deeper. When we map the actual experience of a medical reviewer, the problem reframes from ‘slow reviewers’ to ‘a system that makes fast review impossible.’ That reframe changes everything about the solution.
Systems Thinking gives us the lens to see where cycle time actually disappears. Our diagnostic consistently reveals that 60-70% of MLR cycle time is not review time — it’s queue time, rework loops, and handoff delays. We map these feedback loops and delay structures so we can intervene at the leverage points, not the symptoms.
Agile provides the sprint cadence, the ceremony structure, and the metrics framework. In the SPRINT Model, agile is adapted for regulated marketing: sprint refinement includes a compliance-risk assessment, sprint review includes a real MLR reviewer, and retrospectives include a reviewer’s voice.
Map where your cycle time actually disappears using value-stream mapping. Most teams discover that actual reviewer time is 3-5 days, but five weeks vanish to queue time and coordination delays. Deliverable: current-state value stream map with cycle-time baseline and leverage points.
Reframe the problem as a system-design challenge, not a people-performance challenge. Define the structural bottleneck: the review process is sequential gate at the end of a linear workflow. Submissions arrive incomplete, reviewers lack context, and rework is high. Deliverable: problem-definition brief with root-cause analysis and design criteria.
Co-design the new operating model with three structural changes: cross-functional pods with shared backlogs, ceremony cadence with embedded MLR reviewers, and real-time governance dashboards. Make MLR review part of the creative process, not a wall at the end. Deliverable: full operating-model specification with pod structure, ceremony design, and governance framework.
Embed the new compliance model into every sprint ceremony. Refinement now includes compliance-risk assessment, sprint planning includes reviewer capacity, and review includes live walkthroughs with reviewers present. Run ceremonies alongside your team for 8-12 weeks with real-time coaching. Deliverable: embedded coaching, ceremony playbooks, and metrics instrumentation.
Train and certify every role in the new operating model. Build a coaching cadence with weekly touchpoints on pod leads, bi-weekly ceremony observation, and monthly leadership reviews. Reposition MLR reviewers from ‘gatekeepers’ to ‘compliance partners’ with metrics that reward collaboration. Deliverable: role-specific training, coaching cadence, change-communication plan, and cultural-shift playbook.
Instrument metrics that matter: cycle time, first-pass approval rate, submission quality score, and delivery predictability. Run quarterly optimization sprints where the team reviews data and adjusts the operating model. Clients typically see biggest gains in the first 90 days with sustained improvement over 12-18 months. Deliverable: metrics dashboard, quarterly optimization playbook, and continuous-improvement cadence.
57%
MLR cycle-time reduction
Valuebound, 2024
75%
First-pass approval rate
Up from ~45% (Veeva Systems, 2024)
90 days
Brand strategy cycle
Down from 2+ years (McKinsey, 2020)
2-3x
Faster content-to-market
With AI pre-screening (Pharmaphorum, 2024)
The MLR SPRINT Model™ is designed for pharmaceutical and biotech organizations where MLR review is the structural bottleneck in marketing execution. It’s particularly effective when:
✓ Your average MLR cycle time exceeds 6 weeks
✓ First-pass approval rates are below 50%
✓ Your agile implementation stalled because it couldn’t accommodate MLR
✓ Cross-functional teams are working in silos despite a ‘pod’ structure on paper
✓ Launch timelines are slipping because content can’t get through review
✓ You’ve tried ‘speeding up MLR’ and it hasn’t worked — because speed isn’t the problem
Every organization’s MLR challenge is different. Book a 30-minute discovery call to discuss your specific bottleneck and whether the SPRINT Model is the right fit.
